What is Biohaven's other accrued liabilities?

Biohaven (BHVN) reported other accrued liabilities of $9.78M in Q1 2026.

How has Biohaven's other accrued liabilities changed year-over-year?

Biohaven's other accrued liabilities decreased by 26.0% year-over-year, from $13.23M to $9.78M.

What is the long-term trend for Biohaven's other accrued liabilities?

Over 4 years (2021 to 2025), Biohaven's other accrued liabilities has grown at a 24.6% compound annual growth rate (CAGR), from $3.57M to $8.61M.

Biohaven BHVN Other accrued liabilities

Other accrued liabilities at other companies

Vir Biotechnology, Inc.VIR

——

Roivant SciencesROIV

——

BridgeBio PharmaBBIO

——

ADMA BiologicsADMA

——

Viridian Therapeutics, Inc.VRDN

——

Immunovant, Inc.IMVT

——

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's other accrued liabilities?: Biohaven (BHVN) reported other accrued liabilities of $9.78M in Q1 2026.
How has Biohaven's other accrued liabilities changed year-over-year?: Biohaven's other accrued liabilities decreased by 26.0% year-over-year, from $13.23M to $9.78M.
What is the long-term trend for Biohaven's other accrued liabilities?: Over 4 years (2021 to 2025), Biohaven's other accrued liabilities has grown at a 24.6% compound annual growth rate (CAGR), from $3.57M to $8.61M.